Literature DB >> 1709435

HCV transmission after receiving anti-c100-negative blood units.

S Inaba, M Fukuda, K Okochi, Y Irita, K Tokunaga, H Kiyokawa, Y Maeda.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1709435     DOI： 10.1016/0140-6736(91)93036-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Evaluation of three hepatitis C virus-related antibodies C100, KCL-163, JCC. Tests for screening blood donors.

Authors:  S Fujiyama; S Kawano; S Sato; T Sato; T Kawahara; K Mizuno; Y Kusumoto; M Esumi; T Shikata
Journal:  Dig Dis Sci       Date:  1992-10       Impact factor: 3.199

2.  Immunodominant regions within the hepatitis C virus core and putative matrix proteins.

Authors:  M Sällberg; U Rudén; B Wahren; L O Magnius
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

3.  Rationale for preoperative screening of anti-HCV antibody.

Authors:  Y Sakaguchi; S Inaba; J Yoshitake
Journal:  J Anesth       Date:  1993-01       Impact factor: 2.078

4.  Vertical transmission of hepatitis C virus (HCV) detected by HCV-RNA analysis.

Authors:  T Kuroki; S Nishiguchi; K Fukuda; N Ikeoka; R Murata; G Isshiki; S Tomoda; S Ogita; T Monna; K Kobayashi
Journal:  Gut       Date:  1993       Impact factor: 23.059

5.  Peptide based enzyme immunoassays for detecting hepatitis C antibodies in sera of people at high risk.

Authors:  F G Gabriel; C G Teo
Journal:  J Clin Pathol       Date:  1994-04       Impact factor: 3.411
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.